相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
Mika Hilvo et al.
CANCER RESEARCH (2011)
Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: An Indian cohort study
S. Vandhana et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Fatty Acid Synthase Inhibition by Amentoflavone Induces Apoptosis and Antiproliferation in Human Breast Cancer Cells
Jin Sun Lee et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-ketoacyl reductase reaction
Maria Jesus Vazquez et al.
FEBS JOURNAL (2008)
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction
Hailan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells
Tik-Shun Ho et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride
Lucy J. Schmidt et al.
PROSTATE (2007)
Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?
Ruth Lupu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2006)
Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity
K Brusselmans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer
SY Lu et al.
CARCINOGENESIS (2005)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
SJ Kridel et al.
CANCER RESEARCH (2004)
Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells
SJ Qiao et al.
FEBS LETTERS (2004)
Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness
FD Camassei et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Key role of mitochondria in cerulenin-mediated apoptosis
SJ Heiligtag et al.
CELL DEATH AND DIFFERENTIATION (2002)
Orlistat: its current status as an anti-obesity drug
A Ballinger et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells
BQ Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Risk factors for metastasis in retinoblastoma
PT Finger et al.
SURVEY OF OPHTHALMOLOGY (2002)
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity
JN Thupari et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Synthesis and antitumor activity of an inhibitor of fatty acid synthase
FP Kuhajda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)